Cytosorbents (CTSO) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Cytosorbents (CTSO) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -10.66% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 61.88% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 46.62% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -36.73% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -2.41% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 100.22% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -35.05% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.28% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | 68.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.74% |
| Dec 31, 2025 | -2.47% |
| Sep 30, 2025 | 4.48% |
| Jun 30, 2025 | 76.06% |
| Mar 31, 2025 | 13.23% |
| Dec 31, 2024 | -15.88% |
| Sep 30, 2024 | -62.09% |
| Jun 30, 2024 | -265.96% |
| Mar 31, 2024 | 40.94% |
| Dec 31, 2023 | 31.94% |
| Sep 30, 2023 | -233.84% |
| Jun 30, 2023 | -27.97% |
| Mar 31, 2023 | -17.05% |
| Dec 31, 2022 | 54.77% |
| Sep 30, 2022 | -32.69% |
| Jun 30, 2022 | -143.36% |
| Mar 31, 2022 | 16.58% |
| Dec 31, 2021 | 50.72% |
| Sep 30, 2021 | 63.78% |
| Jun 30, 2021 | 67.58% |